Alzheimer’s News

December 13, 2019December 13, 2019

Phase 1 Trial for Potential Alzheimer’s Therapy Yields Positive Results

Alzheimer's disease, Alzheimer's News, News

A recent Phase 1 clinical study of a potential Alzheimer’s therapy showed positive results regarding both safety and biomarkers for cognitive processes. The data support advancing the investigational compound, NDX-1017, ... Read more

May 20, 2019May 20, 2019

Investigational Alzheimer’s Therapy NNI-362 Receives FDA Approval to Enter Phase 1 Clinical Studies

Alzheimer's News, News

The U.S. Food and Drug Administration has approved Neuronascent’s investigational new drug (IND) application for NNI-362, its therapy candidate for Alzheimer’s disease, allowing it to move ahead with a ... Read more

October 6, 2017

Acadia Is Starting Phase 3 Trial of Nuplazid for Dementia-related Psychosis

Alzheimer's News, News

Acadia Pharmaceuticals is starting its Phase 3 HARMONY trial to evaluate Nuplazid (pimavanserin) as a treatment for hallucinations and delusions associated with dementia-related psychosis. Currently, there is no approved therapy for ... Read more

June 9, 2017June 9, 2017

3 New Studies Will Add to IDEAS Research on Dementia Causes and Care

Alzheimer's News, News

The $100 million IDEAS (Imaging Dementia — Evidence for Amyloid Scanning) Study is working closely with researchers and government officials to add three additional studies to the main project, where more than 18,000 people ... Read more

May 9, 2017May 9, 2017

Patient Advocacy Groups Welcome 40% Increase in Alzheimer’s NIH Research Funds Authorized by Congress

Alzheimer's News, News

The U.S. Congress last week authorized an additional 40 percent in funds for Alzheimer’s disease (AD) research, boosting the fiscal 2017 total by $400 million to nearly $1.4 billion as ... Read more

June 6, 2016June 6, 2016

New Research Reveals Certain Protein Protects Against Neurodegenerative Diseases

Alzheimer's News, News

A new study led by biomedical scientists at Indiana University has revealed evidence that the NMNAT2 enzyme may be protective against the debilitating effects of certain degenerative disorders, including Alzheimer’s Disease. ... Read more

February 26, 2016February 27, 2016

Partnership Yields Alzheimer’s Diagnostic Breakthrough at 2 Canadian Universities

Alzheimer's News, News

A collaboration between researchers at two universities in Halifax, Nova Scotia, in Canada has resulted in the discovery of an innovative, non-invasive diagnostic agent for Alzheimer’s disease, where before ... Read more

December 1, 2015December 1, 2015

Exercise Boosts the Brain In Alzheimer’s Patients, According to Research

Alzheimer's News, News

It is widely accepted that exercise is good for your health, but can it even increase brain cells? That is the conclusion from several new reports published in the first issue ... Read more

November 25, 2015November 25, 2015

Amyloid Plaques Found To Build Up Around Brain’s Blood Vessels Involved in Alzheimer’s Disease

Alzheimer's News, News

Amyloid plaques impair astrocyte function to regulate brain vessels’ blood flow in Alzheimer’s disease. These are the findings from a study entitled “Vascular amyloidosis impairs the gliovascular unit in a mouse model ... Read more

October 5, 2015October 5, 2015

miRNAs in Exosomes May Serve as Basis for New Alzheimer Diagnostic Tests

Alzheimer's News, dementia, News

As a disease that is best detected and treated early after onset, Alzheimer disease is characterized by a variety of aberrantly regulated proteins and molecules, which once identified can be ... Read more